Pure Extracts: Recurring Revenue with Blue Sky Potential


Ryan Allway

November 17th, 2020

App, Exclusive, News, Top Story


The global cannabis extract market is projected to reach $28.5 billion by 2027, according to Grand View Research, representing a 16.6% compound annual growth rate. In addition to the relatively mature cannabis market, the wider market for plant-based extracts could see tremendous growth from the functional mushroom revolution.

Let’s take a look at how Pure Extracts Technologies Corp.’s (CSE: PULL) unique combination of recurring revenue and blue sky potential has opened the door for investors.

Recurring Tolling Revenue

Pure Extracts operates a 10,000 sq. ft. state-of-the-art EU-GMP-compliant cannabis and hemp extraction facility with a Health Canada Standard Processing License. With existing contracts secured with licensed producers, the Company is already generating revenue through tolling and white label agreements where it converts biomass into higher value extracts.

CEO Ben Nikolaevsky discusses the breakdown of Pure Extracts extraction business model

  • Tolling takes biomass from licensed producers, runs an extraction process and returns the cannabis oil to the LP for a fee to put into their own products or resell.
  • White-labeling takes biomass from licensed producers, runs an extraction process and produces a range of products, such as vapes or tinctures, that LPs can sell.

Over the coming quarters, the Company plans to expand its production capacity to process upwards of 100,000 kilograms per year. The Company also plans to apply for a Natural Health Products Site License for the extraction of mushroom compounds and apply for EU-GMP certification of its operations to eventually export products to Europe.

Click here to receive and investor presentation and corporate updates

Blue Sky Branding Potential

Pure Extracts has developed a nationally-recognized vape pen brand called Pure Pulls with over 34 proprietary formulations. While the Company’s vape brand is well known, the Company also plans to launch tinctures, soft gel capsules and other products on both a branded and private label basis across the country.

CEO Ben Nikolaevsky discusses Pure Extracts’ value proposition

In addition to launching its own products, the Company has continued to double down on its investment in research and development. Dr. Alexander MacGregor, a leading Canadian scientist and founder of the Toronto Institute of Pharmaceutical Technology (TIPT), recently joined the Company in an advisory role to advance its research and development.

Dr. MacGregor has a narcotics license that opens the door to research into psilocybin production. As the Canadian medical community adopts psilocybin, the Company aims to leverage its functional mushroom experience to apply for a Dealer’s License and eventually become a leading supplier of pharmaceutical grade mushroom extracts into the medical space.

Click here to receive and investor presentation and corporate updates

Looking Ahead

Pure Extracts Technologies Corp. (CSE: PULL) is well positioned for rapid growth in the plant-based extract sector with 34 proprietary formulations and plans to expand into functional mushrooms. In addition to its commercial ambitions, the Company also continues to invest in research and development initiatives under the guidance of its new advisor, Dr. Alexander MacGregor.

Investors may want to take a closer look at the newly public company due to its unique combination of processing agreements and blue sky potential. With established sources of recurring revenue, Pure Extracts has access to the cash flow that it needs to invest in its own products and research that will have even greater long-term potential.

For more information, visit the Company’s website or download their investor presentation.

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading